C

China National Accord Medicines Corp Ltd
SZSE:000028

Watchlist Manager
China National Accord Medicines Corp Ltd
SZSE:000028
Watchlist
Price: 25 CNY -0.75% Market Closed
Market Cap: ¥13.9B

China National Accord Medicines Corp Ltd's latest stock split occurred on Jun 1, 2023

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, China National Accord Medicines Corp Ltd traded at 58.5 per share. Afterward, the share price was about 42.73.

The adjusted shares began trading on Jun 1, 2023. This was China National Accord Medicines Corp Ltd's 6th stock split, following the previous one in Sep 11, 2000.

Last Splits:
Jun 1, 2023
1-for-1
Sep 11, 2000
1-for-1
Nov 12, 1996
1-for-1
Jul 16, 1996
105-for-100
Sep 6, 1995
11-for-10
Pre-Split Price
44.2 58.5
Post-Split Price
42.73
Before
After
Last Splits:
Jun 1, 2023
1-for-1
Sep 11, 2000
1-for-1
Nov 12, 1996
1-for-1
Jul 16, 1996
105-for-100
Sep 6, 1995
11-for-10

China National Accord Medicines Corp Ltd
Stock Splits History

China National Accord Medicines Corp Ltd Stock Splits Timeline
Jun 1, 2023
Jun 1, 2023
Split 1-for-1
/1
Pre-Split Price
44.2 58.5
Post-Split Price
42.73
Before
After
Sep 11, 2000
Sep 11, 2000
Split 1-for-1
/1
Pre-Split Price
N/A
Post-Split Price
22.246
Before
After
Nov 12, 1996
Nov 12, 1996
Split 1-for-1
/1
Pre-Split Price
N/A
Post-Split Price
22.246
Before
After
Jul 16, 1996
Jul 16, 1996
Split 105-for-100
x1.05
Pre-Split Price
N/A
Post-Split Price
22.246
Before
After
Sep 6, 1995
Sep 6, 1995
Split 11-for-10
x1.1
Pre-Split Price
N/A
Post-Split Price
22.246
Before
After
Aug 31, 1994
Aug 31, 1994
Split 11-for-10
x1.1
Pre-Split Price
N/A
Post-Split Price
22.246
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 24, 2026
Cue Biopharma Inc
NASDAQ:CUE
1-for-30
/30
0.5542 16.626 USD 17.695 17.695 USD
Apr 24, 2026
Medical Data Vision Co Ltd
TSE:3902
2-for-7253607
/3626803.5
1684 1684 JPY N/A
Apr 24, 2026
T
Trillion Energy International Inc
CNSX:TCF
1-for-5
/5
0.2 0.2 CAD 0.18 0.18 CAD
Apr 24, 2026
E
ESGL Holdings Ltd
NASDAQ:ESGL
1-for-3
/3
2.35 7.05 USD 2.93 2.93 USD
Apr 24, 2026
Metro Mining Ltd
ASX:MMI
1-for-20
/20
0.067 1.34 AUD 1.3 1.3 AUD
Load More

China National Accord Medicines Corp Ltd
Glance View

Market Cap
13.9B CNY
Industry
Health Care

China National Accord Medicines Corp Ltd, nestled within the bustling healthcare landscape of China, operates at the heart of the pharmaceutical distribution and retail sectors. Established with the goal of ensuring that essential medicines and healthcare services are accessible to the vast Chinese population, the company has built an extensive distribution network. This network efficiently links manufacturers with hospitals, clinics, and pharmacies, making certain that a myriad of pharmaceutical products reach their intended destinations. By leveraging a combination of logistical prowess and vast geographical coverage, the company adeptly navigates the complexities of supply chain management, underscoring its role as a critical player in China's healthcare infrastructure. Beyond distribution, China National Accord Medicines also capitalizes on the booming retail pharmaceuticals market through its chain of pharmacies. These retail outlets serve as direct points of sale to consumers, offering both prescription and over-the-counter medications, alongside health consultation services. This dual focus on both wholesale distribution and retail outlets enables the company to capture value across the supply chain, from manufacturer to end-user. The strategic alignment of its operations streamlines efficiency and generates revenue, sustaining its growth amid a fiercely competitive and rapidly evolving market. Through this integrated approach, the company solidifies its position as a crucial conduit in the delivery of healthcare solutions across China.

Intrinsic Value
73.5 CNY
Undervaluation 66%
Intrinsic Value
Price ¥25
C
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett